Thryv Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
999 Boul De Maisonneuve O Suite 1250, Mo...Phone Number
(514) 973-0915Website
www.thryvtrx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Thryv Therapeutics
Thryv Therapeutics is pioneering a precision medicine approach to treat genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase.Explore more
Thryv Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Thryv Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Thryv Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Thryv Therapeutics
Click to see if Thryv Therapeutics had a recent Job posting/layoffs
Check if Thryv Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Thryv Therapeutics is spiking on competitors!
Thryv Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Thryv Therapeutics has new funding data
Product Launch: Get notified when Thryv Therapeutics launches new products
Recommended Actions
Find VP level buyers at Thryv Therapeutics
Find 2 more new buyers
Compare Similar Companies to Thryv Therapeutics
Compare insights from companies similar to Thryv Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$5.4M
11-50
Private
$237M
-
DD
D. Michael DixonChief Financial Officer and Chef De La Direction Financière
Company Profile Activity
Activity Insights
Thryv Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Thryv Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Thryv Therapeutics.
Thryv Therapeutics Tech Stack
A closer look at the technologies used by Thryv Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Thryv Therapeutics
Sign Up For FreeTo access detailed company insights
Thryv Therapeutics is pioneering a precision medicine approach to treat genetic and drug-induced Long QT Syndromes, atrial fibrillation, and resistant cancers with potent and selective inhibitors of Serum Glucocorticoid inducible Kinase.... Read More
